Suven is an integrated pharma and specialty chemical CDMO company. It has grown at 16%+ CAGR over the last 10 years and has 40%+ EBITDA margins according to claims made in the filings.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
